The Gene Amplification Technologies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A Rise in Demand for Genetic Data Collecting to Identify and Map Every Gene in the Human Genome Is Causing the Global Market to Expand
Gene amplification is the differential expansion of a certain region of the genome relative to the rest. Most species appear to engage in this process, which has been demonstrated to take place in both somatic and germline cells. Gene Amplification can have positive such as a growth or survival benefit or negative effects on the organism. It can be linked to normal developmental processes or occur as spontaneous genetic events. Somatic cell gene amplification in human malignancies has lately received substantial research. Proto-oncogene amplification may cause or contribute to the development of tumours. The amplified gene may occasionally serve as a viable target for cancer treatment. It mentions the growth of a certain DNA from a very little volume. A rise in demand for genetic data collecting to identify and map every gene in the human genome is causing the global market to expand. The global market for gene amplification technology is being driven by the widespread acceptance of specific cancer therapies. Human Genome Projects continue to be the primary factor driving the market for gene amplification technology (HGP).
The Growing Adoption of Customised Medicine, and Expanding Research in Molecular Diagnostics and Genomics Are the Key Market Drivers
The arrival of fresh and cutting-edge products, the growing adoption of customised medicine, and expanding research in molecular diagnostics and genomics are the key market drivers. In the near future, it is projected that rising genomics investments by pharmaceutical and biotechnology businesses would significantly fuel the industry. The biotechnology industry has recently seen a considerable shift toward novel pharmaceuticals and therapies, medicines based on genome sequencing, and technological developments, which has fuelled market expansion. The commercial adoption of gene multiplication techniques has been affected by improvements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeframe. The industry for gene multiplication technology has also been boosted by international projects like the Africa Pathogen Genomics Initiative (Africa PGI).
What Questions Should You Ask before Buying a Market Research Report?
• How is the gene amplification technologies market evolving?
• What is driving and restraining the gene amplification technologies market?
• How will each gene amplification technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each gene amplification technologies submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading gene amplification technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the gene amplification technologies projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of gene amplification technologies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the gene amplification technologies market?
• Where is the gene amplification technologies market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the gene amplification technologies market today, and over the next 10 years:
• Our 425-page report provides 176 tables and 190 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the gene amplification technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising gene amplification technologies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Sample Type
• Single Cell
• Formalin-Fixed & Paraffin-Embedded (FFPE)
Market Segment by End-User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Other End-Users
Market Segment by Business Type
• Gene Amplification Kits & Reagents
• Gene Amplification Instruments
• Gene Amplification Services
• Gene Amplification Ancillaries
Market Segment by Application
• Hybridization Application
• Whole Genome Amplification
• Exome Sequencing Amplification
• SNP Genotyping Arrays
• Array CGH
Market Segment by Technology
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Other Technology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• Turkey
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Gene Amplification Technologies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• 4BASEBIO AG
• Abbott Laboratories
• Agilent Technologies, Inc.
• Ambion Inc.
• Bayer Pharmaceutics AG
• Becton Dickinson and Co.
• Bio-Rad Laboratories
• Danaher Corporation
• Illumina Inc.
• LGC Group
• Merck KGaA
• MyBioSource
• Nanjing Vazyme Biotech Co.
• New England Biolabs
• PerkinElmer Inc.
• Promega Corporation
• Qiagen N.V.
• Silicon Biosystems
• Takara Bio Inc.
• Yikang Inc.
Overall world revenue for Gene Amplification Technologies Market, 2023 to 2033 in terms of value the market will surpass US$4,853 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Gene Amplification Technologies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Gene Amplification Technologies Market, 2023 to 2033 Market, with forecasts for application, technology, sample type, business type, end-user and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the Gene Amplification Technologies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Gene Amplification Technologies Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Gene Amplification Technologies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Gene Amplification Technologies Market Report 2023-2033: Forecasts by Sample Type (Single Cell, Formalin-Fixed & Paraffin-Embedded (FFPE)), by End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other), by Business Type (Gene Amplification Kits & Reagents, Gene Amplification Instruments, Gene Amplification Services, Gene Amplification Ancillaries), by Application (Hybridization Application, Whole Genome Amplification, Exome Sequencing Amplification, SNP Genotyping Arrays, Array CGH), by Technology (PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Gene Amplification Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Research Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Premium Insights
3.1 Geographical Snapshot: Global Gene Amplification Technologies Market
3.2 Technology Segment: Market Attractiveness Index
3.3 Sample Type Segment: Market Attractiveness Index
3.4 End-User Segment: Market Attractiveness Index
3.5 Business Type Segment: Market Attractiveness Index
3.6 Application Segment: Market Attractiveness Index
4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Supply Chain Overview
4.4 Value Chain Overview
4.4.1 Cold Chain
4.5 Recent Trends and Developments
4.6 COVID-19 Impact Analysis
4.7 Porter’s Five Forces Analysis
4.7.1 Supplier Power
4.7.2 Buyer Power
4.7.3 Competitive Rivalry
4.7.4 Threat from Substitutes
4.7.5 Threat of New Entrants
4.8 PESTLE Analysis
4.8.1 Political Factors
4.8.2 Economic Factors
4.8.3 Social Factors
4.8.4 Technological Factors
4.8.5 Legal Factors
4.8.6 Environmental Factors
5 Global Gene Amplification Technologies Market Analysis by Application
5.1 Key Findings
5.2 Global Market Outlook
5.3 Region Segment Growth Prospects
5.4 Global Gene Amplification Technologies Market Share by Region, 2023 & 2033
5.5 Global Gene Amplification Technologies Market Share Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.6 Global Pharma Contract Sales Market by Region Size Estimation and Forecast
5.6.1 Pre-COVID-19 Market Scenario
5.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Gene Amplification Technologies Market Analysis by Technology
6.1 Key Findings
6.2 Global Technology Market Outlook
6.3 Global Gene Amplification by Technology Market Attractiveness Index
6.4 Regional Market Size Estimation and Forecast
6.5 Amplification based on PCR
6.5.2 Global PCR-based Amplification Market Forecast
6.5.3 Global Cleavable Linkers Market Forecast by Region
6.6 Loop-mediated Isothermal Amplification
6.7 Global Loop-mediated Isothermal Amplification Market Forecast
6.7.1 Global Loop-mediated Isothermal Amplification Market Forecast by Region
6.8 Nucleic Acid Sequence Based Amplification
6.8.1 Nucleic Acid Sequence Based Amplification Market Forecast
6.8.2 Global Nucleic Acid Sequence Based Amplification Market Forecast by Region
6.9 Strand Displacement Amplification
6.8.3 Strand Displacement Amplification Market Forecast
6.8.4 Global Strand Displacement Amplification Market Forecast by Region
6.10 Multiple Displacement Amplification
6.10.1 Multiple Displacement Amplification Market Forecast
6.8.5 Global Multiple Displacement Amplification Market Forecast by Region
6.11 Other Technology Amplification
6.8.6 Other Technology Amplification Market Forecast
7 Global Gene Amplification Technologies Market Analysis by Sample Type
7.1 Key Findings
7.2 Global Sample Type Market Outlook
7.2.1 Global Gene Amplification by Sample Type Market Attractiveness Index
7.3 Global Gene Amplification Technologies Market by Sample Type
7.4 Single Cell
7.4.1 Global Single Cell Market Forecast
7.4.2 Global Single Cell Market Forecast by Region
7.5 Formalin-Fixed, Paraffin-Embedded (FFPE)
7.5.1 Global FFPE Market Forecast
7.5.2 Global FFPE Market Forecast by Region
8 Global Gene Amplification Technologies Market Analysis by End-User
8.1 Key Findings
8.2 Global End-User Market Outlook
8.2.1 Global Gene Amplification by End-User Market Attractiveness Index
8.3 Global Gene Amplification Technologies Market by End-User Antigen
8.4 Pharmaceutical & Biotechnological Companies
8.4.1 Global Pharmaceutical & Biotechnological Companies Market Forecast
8.4.2 Global Pharmaceutical & Biotechnological Companies Market Forecast by Region
8.5 Academic & Research Institute
8.5.1 Global Academic & Research Institute Market Forecast
8.5.2 Global Academic & Research Institute Market Forecast by End-User
9 Global Gene Amplification Technologies Market Analysis by Business Type
9.1 Key Findings
9.2 Global Business Type Market Outlook
9.2.1 Global Gene Amplification by Business Type Market Attractiveness Index
9.3 Global Gene Amplification Technologies Market by Business Type
9.4 Kits & Reagents
9.4.1 Global Kits & Reagents Market Forecast
9.4.2 Global Kits & Reagents Market by Region
9.5 Instruments
9.5.1 Global Instruments Market Forecast
9.5.2 Global Instruments Market by Region
9.6 Services
9.6.1 Global Services Market Forecast
9.6.2 Global Services Market by Region
9.7 Ancillaries
9.7.1 Global Ancillaries Market Forecast
9.7.2 Global Ancillaries Market by Region
10 North America Market Analysis
10.1 Key Findings
10.2 Overview
10.2.2 North America Gene Amplification Technologies Market Attractiveness Index
10.3 North America Gene Amplification Technologies Market Size and Forecast by Value
10.4 North Gene Amplification Technologies Market Size Estimation and Forecast by Country
10.5 North America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
10.6 North America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
10.7 North America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
10.8 North America Gene Amplification Technologies Market Size Estimation and Forecast by Application
10.9 North America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
10.10 US Market
10.10.1 The US Government's Foreign Investment Risk
10.10.2 The American Pharmaceutical Research and Manufacturers
10.11 Canada Market
10.11.1 Control of Laboratory-Developed Tests
10.11.2 Drug-related Expenses
11 Europe Market Analysis
11.1 Key Findings
11.2 Overview
11.3 Europe Gene Amplification Technologies Market Attractiveness Index
11.5 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Country
11.4 Europe Gene Amplification Technologies Market Size and Forecast by Value
11.6 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
11.7 Europe Gene Amplification Technologies Market Size Estimation and Forecast by End-User
11.8 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
11.9 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Application
11.10 Europe Gene Amplification Technologies Market Size Estimation and Forecast by Technology
11.2 Germany Market
11.2.1 Germany Has a Robust and Broad Market
11.2.2 Inventive IVD industry
11.3 UK Market
11.3.1 UK Guidelines for Microbiology Examinations (UK SMIs)
11.3.2 The NHS Has Made Clinically-Directed Genetic Testing Available for Molecular Genetic Analysis
11.4 France Market
11.4.1 Molecular Diagnostics Market Expansion in France
11.4.2 Foreign Organisations Investing in France
11.5 Italy Market
11.5.1 Italian Pharmaceuticals' Advantage
11.5.2 Nucleic Acid Amplification Technology's (NAT) Effects in Italy
11.6 Spain Market
11.6.1 Spanish Clinical Genetics and Genomics
11.6.2 Expansion of Spain's pharmaceutical and R&D Industries
11.15 Rest of Europe Market Analysis
12 Asia-Pacific Market Analysis
12.1 Key Findings
12.2 Overview
12.2.1 The Commercial Effect of Polymerase Chain Reactions
12.2.2 Asia-Pacific Market for Gene Therapy
12.3 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
12.4 Asia-Pacific Gene Amplification Technologies Market Size and Forecast by Value
12.5 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
12.7 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by End-User
12.8 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
12.9 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Application
12.10 Asia-Pacific Gene Amplification Technologies Market Size Estimation and Forecast by Technology
12.3 China Market
12.3.1 China's Molecular Diagnostics Market Is Going to Expand At a Faster Rate Than That of Other Nations
12.3.2 Market Segment Analysis for Molecular Diagnostics
12.4 India Market
12.4.1 Advancements in POC Diagnostic Technology
12.4.2 India's Genome Engineering Technology Regulations
12.5 Japan Market
12.5.1 Japan's Ability to Use Genomic Medicine
12.5.2 Developments in Japanese Genetic Testing Regulation
12.14 South Korea Market
12.5.3 Pharmaceutical Industry Development in South Korea
12.6 Australia Market
12.6.1 Nucleic Acid Amplification Assays for Active Mycobacterial Infection
12.6.2 Australia Is a Dynamic Centre for the Biological Sciences with a Worldwide Reach
12.7 Rest of Asia-Pacific Market Analysis
13 Middle East & Africa Market Analysis
13.1 Key Findings
13.2 Overview
13.2.1 MENA's Expanding Pharmaceutical Industry
13.2.2 MENA's Regulatory Environment
13.3 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
13.4 Middle East & Africa Gene Amplification Technologies Market Size and Forecast by Value
13.5 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Country
13.6 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
13.7 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by End-User
13.8 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
13.9 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Application
13.10 Middle East & Africa Gene Amplification Technologies Market Size Estimation and Forecast by Technology
13.3 South Africa Market Analysis
13.3.1 On the African Continent, South Africa Has the Biggest Life Sciences Market
13.4 Saudi Arabia Market Analysis
13.4.1 Pharmacy Research and Development of Saudi Arabia
13.4.2 Rules and Regulations
13.5 Turkey Market Analysis
13.5.1 Turkish Regulatory Authority
13.5.2 Updates to the Recommendations for PCR Testing
13.6 Rest of Middle East and Africa Market Analysis
14 Latin America Market Analysis
14.1 Key Findings
14.2 Overview
14.2.1 Significantly Raise in Latin American Pharmaceutical Industry
14.2.2 Comparison with Other Industries and Analysis of the Direct, Indirect, and Induced Impacts
14.3 Latin America Gene Amplification Technologies Market Attractiveness Index
14.4 Latin America Gene Amplification Technologies Market Size and Forecast by Value
14.5 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Country
14.6 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Sample Type
14.7 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by End-User
14.8 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Business Type
14.9 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Application
14.10 Latin America Gene Amplification Technologies Market Size Estimation and Forecast by Technology
14.11 Brazil Market
14.2.3 Brazil's Loop-Mediated Isothermal Amplification (LAMP) Assay Development and Clinical Evaluation for the Diagnosis of Human Visceral Leishmaniasis
14.2.4 Brazilian Government Regulations and Policies
14.3 Mexico Market
14.3.1 Mexican Pharmaceutical Firms Take Advantage of Market Circumstances
14.13 Rest of Latin America Market Analysis
15 Competitive Landscape
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Collaboration
15.5 Key Business Strategy Analysis- Expansion
15.6 Key Business Strategy Analysis- Investment
15.7 Key Business Strategy Analysis- New Product Launch
15.8 Key Business Strategy Analysis- Partnership
15.9 Key Business Strategy Analysis- Development
15.10 Key Business Strategy Analysis- Joint Venture
16 Company Profiles
16.1 Merck KGaA
16.1.2 Company Snapshot
16.1.3 Company Overview
16.1.4 Financial Analysis
16.1.5 Product Benchmarking
16.1.6 Strategic Outlook
16.2 4BASEBIO AG
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Abbott Laboratories (U.S.)
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Agilent Technologies, Inc. (U.S.)
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Ambion Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.5.4 Strategic Outlook
16.6 Bayer Pharmaceutics
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Becton Dickinson and Co.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.8.4 Product Benchmarking
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Bio-Rad Laboratories
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.5 Strategic Outlook
16.9 MyBioSource
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Product Benchmarking
16.9.4 Strategic Outlook
16.10 Danaher Corporation
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Illumina Inc.
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 LGC Group
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Product Benchmarking
16.12.4 Strategic Outlook
16.13 Nanjing Vazyme Biotech Co.
16.13.1 Company Snapshot
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 New England Biolabs
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.14.4 Strategic Outlook
16.15 PerkinElmer Inc.
16.15.1 Company Snapshot
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook
16.16 Promega Corporation
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Strategic Outlook
16.17 Qiagen N.V.
16.17.1 Company Snapshot
16.17.3 Financial Analysis
16.17.4 Product Benchmarking
16.17.5 Strategic Outlook
16.18 Silicon Biosystems
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.18.4 Strategic Outlook
16.19 Takara Bio Inc.
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Financial Analysis
16.19.4 Product Benchmarking
16.19.5 Strategic Outlook
16.20 Yikang Inc.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Product Benchmarking
16.20.4 Strategic Outlook
17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
List of Tables
Table 1 Global Gene Amplification Technologies Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 4 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 5 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 6 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 7 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 8 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 9 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 10 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 11 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 12 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 13 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 14 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%))
Table 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (USD Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 19 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 20 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 21 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 22 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 23 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 25 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 26 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 29 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 30 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 31 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 32 Global Other Technology Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 33 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 34 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 35 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 36 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 37 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 40 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 41 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 42 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 43 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 44 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 45 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 46 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 47 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 50 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 51 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 52 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 53 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 54 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 56 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 58 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 59 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 60 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 61 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 62 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 63 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 64 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 65 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 66 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 67 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 68 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 69 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 70 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 71 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 72 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 73 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 74 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 75 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 76 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 77 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 78 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 79 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 80 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 81 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 82 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 83 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 84 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 85 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 86 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 87 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 88 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 89 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 90 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 91 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 92 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 93 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 94 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 95 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 96 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 97 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 98 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 99 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 100 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 101 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 104 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 105 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 106 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 107 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 108 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 109 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 110 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 111 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 112 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 113 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 114 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 115 Key Business Strategies Adopted by Key Players in Global Gene Amplification Technologies Market
Table 116 Key Business Strategies Adopted by Key Players in Gene Amplification Technologies Market
Table 117 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Merck KGaA: Product Benchmarking
Table 119 Merck KGaA: Strategic Outlook
Table 120 4BASEBIO AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 4BASEBIO AG: Product Benchmarking
Table 122 4BASEBIO AG: Strategic Outlook
Table 123 Abbott Laboratories (U.S.), : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Abbott Laboratories (U.S.),: Product Benchmarking
Table 125 Abbott Laboratories (U.S.),: Strategic Outlook
Table 126 Agilent Technologies, Inc. (U.S.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Agilent Technologies, Inc. (U.S.): Product Benchmarking
Table 128 Agilent Technologies, Inc. (U.S.): Strategic Outlook
Table 129 Ambion Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Ambion Inc.: Product Benchmarking
Table 131 Ambion Inc.: Strategic Outlook
Table 132 Bayer Pharmaceutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Bayer Pharmaceutics: Product Benchmarking
Table 134 Bayer Pharmaceutics: Strategic Outlook
Table 135 Becton Dickinson and Co.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Bio-Rad Laboratories: Product Benchmarking
Table 137 Becton Dickinson and Co.: Product Benchmarking
Table 138 Becton Dickinson and Co.: Strategic Outlook
Table 139 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Bio-Rad Laboratories: Strategic Outlook
Table 141 MyBioSource: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 MyBioSource: Product Benchmarking
Table 143 MyBioSource: Strategic Outlook
Table 144 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 Danaher Corporation: Product Benchmarking
Table 146 Danaher Corporation: Strategic Outlook
Table 147 Illumina Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 Illumina Inc: Product Benchmarking
Table 149 Illumina Inc: Strategic Outlook
Table 150 LGC Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 LGC Group: Product Benchmarking
Table 152 LGC Group: Strategic Outlook
Table 153 Nanjing Vazyme Biotech Co: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Nanjing Vazyme Biotech Co: Product Benchmarking
Table 155 Nanjing Vazyme Biotech Co: Strategic Outlook
Table 156 New England Biolabs: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 157 New England Biolabs: Product Benchmarking
Table 158 New England Biolabs: Strategic Outlook
Table 159 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 160 PerkinElmer Inc.: Product Benchmarking
Table 161 PerkinElmer Inc.: Strategic Outlook
Table 162 Promega Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 Promega Corporation: Product Benchmarking
Table 164 Promega Corporation: Strategic Outlook
Table 165 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Qiagen N.V.: Product Benchmarking
Table 167 Qiagen N.V.: Strategic Outlook
Table 168 Silicon Biosystems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Silicon Biosystems: Product Benchmarking
Table 170 Silicon Biosystems: Strategic Outlook
Table 171 Takara Bio Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 172 Takara Bio Inc: Product Benchmarking
Table 173 Takara Bio Inc: Strategic Outlook
Table 174 Yikang Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 175 Yikang Inc.: Product Benchmarking
Table 176 Yikang Inc.: Strategic Outlook
List of Figures
Figure 1 Global Gene Amplification Technologies Market Segmentation
Figure 2 Breakdown of Primary Interviews by Company Type, Designation, & Region
Figure 3 Global Gene Amplification Technologies Market Forecast by Region: Market Attractiveness Index
Figure 4 Global Gene Amplification Technologies Market by Technology: Market Attractiveness Index
Figure 5 Global Gene Amplification Technologies Market by Sample Type: Market Attractiveness Index
Figure 6 Global Gene Amplification Technologies Market by End-User: Market Attractiveness Index
Figure 7 Global Gene Amplification Technologies Market by Business Type: Market Attractiveness Index
Figure 8 Global Gene Amplification Technologies Market by Application: Market Attractiveness Index
Figure 9 Global Gene Amplification Technologies Market: Market Dynamics
Figure 10 Global COVID Impact Analysis: Gene Amplification Technologies Market Recovery Scenarios
Figure 11 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 12 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Figure 13 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 14 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U – Shaped Recovery)
Figure 15 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W – Shaped Recovery)
Figure 16 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 17 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L – Shaped Recovery)
Figure 18 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 19 Global A Market: Porter’s Five Forces Analysis
Figure 20 Global Gene Amplification Technologies Market: PESTLE Analysis
Figure 21 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 22 Global Gene Amplification Technologies Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 23 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 24 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 25 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 26 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 27 Global Gene Amplification Technologies Market Forecast, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 28 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 29 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 30 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 31 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 32 Global Gene Amplification Technologies Market by Region, 2023-2033 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 33 Global Gene Amplification by Technology Market Attractiveness Index
Figure 34 Global Gene Amplification Technologies Market Forecast by Technology 2023, 2033 (Revenue, CAGR%)
Figure 35 Global Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 36 Global PCR-based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 37 Global PCR-based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 38 Global Loop-mediated Isothermal Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 39 Global Loop-mediated Isothermal Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 40 Global Nucleic Acid Sequence Based Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 41 Global Nucleic Acid Sequence Based Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 42 Global Strand Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 43 Global Strand Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 44 Global Multiple Displacement Amplification Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 45 Global Multiple Displacement Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 46 Global Other Technology Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 47 Global Other Technology Amplification Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 48 Global Gene Amplification by Sample Type Market Attractiveness Index
Figure 49 Global Gene Amplification Technologies Market Forecast by Sample Type 2023, 2033 (Revenue, CAGR%)
Figure 50 Global Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 51 Global Single Cell Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 52 Global Single Cell Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 53 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 54 Global Formalin-Fixed & Paraffin-Embedded (FFPE) Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 55 Global Gene Amplification by End-User Market Attractiveness Index
Figure 56 Global Gene Amplification Technologies Market Forecast by End-User 2023, 2033 (Revenue, CAGR%)
Figure 57 Global Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 58 Global Pharmaceutical & Biotechnology Companies Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 59 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 60 Global Academic & Research Institutes Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 61 Global Academic & Research Institutes Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 62 Global Gene Amplification by Business Type Market Attractiveness Index
Figure 63 Global Gene Amplification Technologies Market Forecast by Business Type 2023, 2033 (Revenue, CAGR%)
Figure 64 Global Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 65 Global Gene Amplification Kits & Reagents Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 66 Global Gene Amplification Kits & Reagents Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 67 Global Gene Amplification Instruments Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 68 Global Gene Amplification Instruments Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 69 Global Gene Amplification Services Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 70 Global Gene Amplification Services Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 71 Global Gene Amplification Ancillaries Market Forecast, 2023-2033 (US$ Mn, AGR (%))
Figure 72 Global Gene Amplification Ancillaries Market by Region, 2023-2033 (US$ Mn, AGR (%))
Figure 73 North America Gene Amplification Technologies Market Attractiveness Index
Figure 74 North America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 75 North America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 76 North America Gene Amplification Technologies Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 North America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 78 North America Gene Amplification Technologies Market Share Forecast by Sample Type, 2023 & 2033 (%)
Figure 79 North America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 80 North America Gene Amplification Technologies Market Share Forecast by End-User, 2023 & 2033 (%)
Figure 81 North America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 82 North America Gene Amplification Technologies Market Share Forecast by Business Type, 2023 & 2033 (%)
Figure 83 North America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 84 North America Gene Amplification Technologies Market Share Forecast by Application, 2023 & 2033 (%)
Figure 85 North America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 86 North America Gene Amplification Technologies Market Share Forecast by Technology, 2023 & 2033 (%)
Figure 87 US Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 88 Canada Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 89 Europe Gene Amplification Technologies Market Attractiveness Index
Figure 90 Europe Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 91 Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 92 Europe Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 93 Europe Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 94 Europe Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 95 Europe Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 96 Europe Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 97 Germany Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 98 UK Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 99 France Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 100 Italy Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 101 Spain Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 102 Rest of Europe Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 103 Asia-Pacific Gene Amplification Technologies Market Attractiveness Index
Figure 104 Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 105 Asia-Pacific Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 106 Asia-Pacific Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 107 Asia-Pacific Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 108 Asia-Pacific Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 109 Asia-Pacific Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 110 Asia-Pacific Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 111 China Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 112 India Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 113 Japan Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 114 South Korea Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 115 Australia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 116 Rest of Asia-Pacific Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 117 Middle East & Africa Gene Amplification Technologies Market Attractiveness Index
Figure 118 Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 119 Middle East & Africa Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 120 Middle East & Africa Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 121 Middle East & Africa Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 122 Middle East & Africa Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 123 Middle East & Africa Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 124 Middle East & Africa Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 125 South Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 126 Saudi Arabia Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 127 Turkey Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 128 Rest of Middle East & Africa Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 129 Latin America Gene Amplification Technologies Market Attractiveness Index
Figure 130 Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 131 Latin America Gene Amplification Technologies Market by Country, 2023-2033 (US$ Mn, AGR (%))
Figure 132 Latin America Gene Amplification Technologies Market by Sample Type, 2023-2033 (US$ Mn, AGR (%))
Figure 133 Latin America Gene Amplification Technologies Market by End-User, 2023-2033 (US$ Mn, AGR (%))
Figure 134 Latin America Gene Amplification Technologies Market by Business Type, 2023-2033 (US$ Mn, AGR (%))
Figure 135 Latin America Gene Amplification Technologies Market by Application, 2023-2033 (US$ Mn, AGR (%))
Figure 136 Latin America Gene Amplification Technologies Market by Technology, 2023-2033 (US$ Mn, AGR (%))
Figure 137 Brazil Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 138 Mexico Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 139 Rest of Latin America Gene Amplification Technologies Market by Value, 2023-2033 (US$ Mn, AGR (%))
Figure 140 Merck KGaA.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 141 Merck KGaA: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 142 Merck KGaA: R&D, 2017-2021 (US$ million, AGR%)
Figure 143 Merck KGaA: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 144 4BASEBIO AG: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 145 4BASEBIO AG: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 146 4BASEBIO AG: R&D, 2017-2021 (US$ million, AGR%)
Figure 147 Abbott Laboratories (U.S.) : Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 148 Abbott Laboratories (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 149 Abbott Laboratories (U.S.),: R&D, 2017-2021 (US$ million, AGR%)
Figure 150 Abbott Laboratories (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 151 Agilent Technologies, Inc. (U.S.): Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 152 Agilent Technologies, Inc. (U.S.): Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 153 Agilent Technologies, Inc. (U.S.): R&D, 2017-2021 (US$ million, AGR%)
Figure 154 Agilent Technologies, Inc. (U.S.): EBITDA, 2017-2021 (US$ million, AGR%)
Figure 155 Bayer Pharmaceutics: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 156 Bayer Pharmaceutics: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 157 Bayer Pharmaceutics: R&D, 2017-2021 (US$ million, AGR%)
Figure 158 Bayer Pharmaceutics: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 159 Becton Dickinson and Co.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 160 Becton Dickinson and Co.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 161 Becton Dickinson and Co.: R&D, 2017-2021 (US$ million, AGR%)
Figure 162 Becton Dickinson and Co.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 163 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 164 Bio-Rad Laboratories: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 165 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 166 Bio-Rad Laboratories: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 167 Danaher Corporation.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 168 Danaher Corporation: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 169 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 170 Danaher Corporation: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 171 Illumina Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 172 Illumina Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 173 Illumina Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Illumina Inc: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 175 Nanjing Vazyme Biotech Co: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 Nanjing Vazyme Biotech Co: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 177 Nanjing Vazyme Biotech Co: R&D, 2017-2021 (US$ million, AGR%)
Figure 178 Nanjing Vazyme Biotech Co: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 179 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 180 PerkinElmer Inc.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 181 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 182 PerkinElmer Inc.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 183 Qiagen N.V.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 184 Qiagen N.V.: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 185 Qiagen N.V.: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 Qiagen N.V.: EBITDA, 2017-2021 (US$ million, AGR%)
Figure 187 Takara Bio Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Takara Bio Inc: Gross Profit, 2017-2021 (US$ million, AGR%)
Figure 189 Takara Bio Inc: R&D, 2017-2021 (US$ million, AGR%)
Figure 190 Takara Bio Inc: EBITDA, 2017-2021 (US$ million, AGR%)
List of Companies Profiled in the report
4BASEBIO AG
Abbott Laboratories
Agilent Technologies, Inc.
Ambion Inc.
Bayer Pharmaceutics AG
Becton Dickinson and Co.
Bio-Rad Laboratories
Danaher Corporation
Illumina Inc.
LGC Group
Merck KGaA
MyBioSource
Nanjing Vazyme Biotech Co.
New England Biolabs
PerkinElmer Inc.
Promega Corporation
Qiagen N.V.
Silicon Biosystems
Takara Bio Inc.
Yikang Inc.
List of Other Companies Mentioned in the report
4D Molecular Therapeutics
Abeona Therapeutics
Actus Therapeutics
Adrenas
Adverum Biotechnologies
Akouos
Amicus Therapeutics
Apollo Therapeutics
Aruvant Sciences
Aspa Therapeutics
Audentes
AVROBIO
Axovant Sciences Ltd
BioVec Pharma
Brainvectis SAS
Catalyst Biosciences
CavoGene Lifesciences
Copernicus Therapeutics
CRISPR Therapeutics AG
Editas Medicine
Enzo Biochem
Errant Gene Therapeutics
Esteve Pharmaceuticals SA
Excision BioTherapeutics
Exonics Therapeutics
Expression Therapeutics
Fibrocell Science
Freeline Therapeutics
Gemini Therapeutics
Generation Bio Corp.
Genethon SA
GenSight Biologics SA
Gyroscope Therapeutics
Hemera Biosciences
Holostem Terapie Avanzate Srl
Homology Medicines
Horama SA
Immusoft Corp.
iTherapeutics Corp.
IVERIC bio
Krystal Biotech
Lamellar Biomedical
Logicbio Therapeutics
Lysogene
Lysogene SAS/ Sarepta Therapeutics
MeiraGTx
Milo Biotechnology
Mustang Bio
NanoScope Technologies
NeuExcell Therapeutics
Nightstar Therapeutics/
Passage Bio
Therapeutics
PTC Therapeutics
Renova Therapeutics
Rocket Pharmaceuticals
Rubius Therapeutics
SanBio Co
Tamid Bio
Telocyte
Temprian Therapeutics
Tocagen
Tolerion
Ultragenyx Pharmaceutical
ViroMed Co Ltd
Vivet Therapeutics SAS
List of Associations Mentioned in the Report
Association of British Pharmaceutical Industry (ABPI)
Central Drugs Standard Control Organization (CDSCO)
Department of Health and Family Welfare
Development and Reform Commission (NDRC)
Food and Drug Administration (US FDA)
Gene Therapy Net
Indian Drug Manufacturer's Association (IDMA)
Informa UK Limited
IntechOpen
International Society of Pharmaceutical Engineering (IPSE)
JOURNAL OF GENERAL VIROLOGY
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer's Association (KPMA)
Massachusetts Medical Society
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health (MOH)
Ministry of Health, Labor and Welfare (MHLW)
Ministry of Industry and Information Technology (MIIT)
National Center for Biotechnology Information
Pan European Networks Ltd
Pharma Manufacturing
Pharmaceutical and Medical Devices Agency (PMDA)
Pharmaceutical-Networking.com
South Americaan Commission
South Americaan Medicines Agency (EMA)
The Alliance for Regenerative Medicine
The Royal Society
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
